AstraZeneca (AZN)
Share price graph
Contact details
Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com
Company information
A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.
Related news from City A.M.
The pay of FTSE 100 bosses fell by nearly a fifth last year on the back of growing investor pressure for restraint. [...]
Investment and trading platform Interactive Investor has revealed its top most-traded for the month of July. [...]
Shares in pharma giant AstraZeneca rose today, after it announced Imfinzi, one of its flagship cancer drugs, had [...]
When defending their companies against hostile takeovers, chief executives usually resort to fairly prosaic and [...]
AstraZeneca shares plunged more than 15 per cent in early trading in London, causing it to become the biggest [...]
Pharmaceuticals giants AstraZeneca and GlaxoSmithKline (GSK) will report half-year results this week, and all [...]
The chief executive of pharmaceuticals giant AstraZeneca has written to staff to stifle rumours he is planning [...]
Shares in pharmaceutical giant AstraZeneca slid in morning trading after reports suggested its chief executive [...]
AstraZeneca today announced the sale of its migraine drug to Germany's Grunenthal. [...]
AstraZeneca today confirmed it priced a three-tranche bond offering totalling $2bn (£1.6bn) yesterday, which is [...]
FTSE 100 pharma giant AstraZeneca has sold the commercial rights to its Seloken heart medicines in Europe for [...]
Shares in AstraZeneca jumped nearly five per cent this morning, boosted by a successful trial of one of its [...]
One of Britain’s top captains of industry breathed a sigh of relief this week when he suggested to me that this [...]
The board of AstraZeneca was left with a bloody nose after nearly 40 per cent of voting shareholders opposed [...]
AstraZeneca said it will turn a corner in the second half of 2017 after facing plummeting revenues as drug patents [...]
Content tagged with "AstraZeneca"